A SUERF report warns that the tariffs imposed by Washington in 2025 will particularly affect the pharmaceutical sector in Europe, hitting countries such as Ireland, Belgium […]

The World Health Organisation explains in an interview with ConSalud.es that the recently launched Global Clinical Trials Forum seeks to combat fragmentation and barriers in research. […]

A new report by Analistas Financieros Internacionales (AFi) highlights the sector’s potential to become a global hub for innovation and drug production. Farmaindustria has presented seven […]

The president of Farmaindustria, Fina Lladós, calls for a regulatory framework that improves the country’s competitiveness in order to turn the current situation of global uncertainty […]

Pharmacists and industry present the updated “Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy” in Barcelona. This is another step towards excellence and improving […]

Our Director of Clinical and Translational Research, Amelia Martín Uranga, participated on Wednesday in Innodata 2025, a national conference on innovation through the use of health […]

20minutos.es Spain is bucking the general decline in cancer clinical trials seen across Europe: it is the only country maintaining its level of research, compared to […]

Gilead held the 6th Advanced Therapies Meeting to celebrate therapeutic advances in the treatment of lymphoma. consalud.es Advanced therapies are transforming the way we understand and […]

Madrid launches a pioneering strategy to become a global benchmark in biopharmaceutical innovation. consalud.es On Monday, the Community of Madrid presented its 2025-2028 Sector Strategy to […]

This “fast track” is one of the sector’s strategic measures in the field of biomedical research and is included in the National Pharmaceutical Industry Strategy. Patients […]

At a time of great challenges in global health research, one of the countries with the most influence in this field is preparing a national strategy […]

A recent study by the Centre for Cell Therapy (CTC) reveals proteins and signalling pathways that are crucial to the effectiveness of CAR-T cells, opening up […]

The director of the ISCIII, Marina Pollán, and the president of Farmaindustria, Fina Lladós, have signed a General Action Protocol to promote research, innovation and knowledge […]

The Pharmaceutical R&D Survey 2024 reflects a steady increase in investment in clinical research over the last decade, which has grown at 7% per year. Direct […]

The XVIII Conference of Biomedical Research Technology Platforms brings together in Madrid more than 200 representatives from public administrations, regulatory agencies, universities and companies to analyse […]

Nathalie Moll (EFPIA) warns in an interview with Health35 that the lack of regulatory consistency and proposed environmental changes threaten investment in biomedical R&D in Europe. […]

In order to host the studies, the centres must have the resources and infrastructure. Gregorio Marañón, La Paz, Clínic de Barcelona and Vall d’Hebron are some […]

Farmaindustria presents improvements to the Draft Medicines Bill to prepare healthcare for innovation in the next 20 yearsThe future law should promote greater investment in healthcare, […]

“It is essential to see medicines and healthcare as an economically and socially very profitable investment for Spain. An investment that generates very important benefits in […]

eleconomista.es In 2023, Spain overtook Germany as the country that initiated the most clinical trials and became the European leader. This is reflected in the report […]

Joint position on the Draft Bill on Medicines and Health ProductsThe proposed system of price regulation for off-patent medicines puts at risk the supply of medicines […]

The International Federation of Innovative Pharmaceutical Industries indicates that the sector invests almost 30% of its revenues in R&D, amounting to nearly 270 billion euros. Diarofarma.com […]

The Regional Minister of Health of Cantabria, César Pascual, inaugurates the 25th CAAC-Pharmaindustry Forum. ‘When we work together, not only do we promote research and biomedical […]

This research momentum means that one in three new medicines approved by Europe in 2024 was classified as an orphan drug. There are still many untreated […]

Getting to know new markets and establishing contacts with both potential customers and potential suppliers. Temperature control in pharmaceutical logistics is one of our pillars, as […]

The President of the Government meets for the second time with around twenty representatives of the national, European and global pharmaceutical industry to intensify public-private collaboration […]

For the first time, a study by the consultancy firm Afi has evaluated the impact of pharmaceutical companies from a dual perspective: the socio-economic value provided […]

37% of all clinical trials being developed in Spain are aimed at treating oncological diseases New drugs are having a direct impact on patient survival, according […]

More than 80 pupils from five schools learn about the process of getting medicines to patients: from R&D to clinical trials The “Bringing science to schools” […]

The European Medicines Agency approved a total of 114 medicines last year, 46 of which had a new active substance, seven more than the previous year. […]